SGLT2 inhibitors vs placebo were associated with reduced heart failure hospitalization among patients with history of myocardial infarction.

Composite of coronary heart disease death and non-fatal myocardial infarction was less frequent in the CCTA group compared to ...

In patients with acute heart failure, it is unclear how body mass index affects clinical outcomes following acute myocardial infarction.

The following is a summary of "Low-dose dobutamine stress myocardial contrast echocardiography for evaluating myocardial ...

The following is a summary of "Impact of sodium-glucose cotransporter‐2 inhibitors in patients with recent versus previous ...

For over two decades, a ‘treatment-risk paradox’ has been described in older adults with cardiovascular disease, with ...

Shenzhen Zhongge Biotechnology Co. Ltd. has identified proteolysis targeting chimera (PROTAC) compounds comprising an E3 ubiquitin ligase binding moiety covalently linked to an interleukin-1 ...

A clot-busting drug recently approved to treat acute ischemic strokes (AIS) that can be delivered quickly works as well as a ...

Researchers have observed that female patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) are more likely to ...

A new review published in Genes & Diseases highlights macrophage-targeted therapy as a promising frontier in cardiac regeneration and myocardial repair.